Glycinergic Transmission Shaped by the Corelease of GABA in a Mammalian Auditory Synapse  by Lu, Tao et al.
Neuron
ArticleGlycinergic Transmission Shaped by the Corelease
of GABA in a Mammalian Auditory Synapse
Tao Lu,1,* Maria E. Rubio,2 and Laurence O. Trussell1
1Oregon Hearing Research Center and Vollum Institute, Oregon Health & Science University, Portland, OR 97239, USA
2Department of Physiology and Neurobiology, University of Connecticut, Storrs, CT 06269, USA
*Correspondence: lut@ohsu.edu
DOI 10.1016/j.neuron.2007.12.010SUMMARY
The firing pattern of neurons is shaped by the conver-
gence of excitation and inhibition, each with finely
tuned magnitude and duration. In an auditory brain-
stem nucleus, glycinergic inhibition features fast de-
cay kinetics, themechanism of which is unknown. By
applying glycine to native or recombinant glycine re-
ceptors, we show that response decay times are ac-
celerated by addition of GABA, aweak partial agonist
of glycine receptors. Systematic variation in agonist
exposure time revealed that fast synaptic time
course may be achieved with submillisecond expo-
sures to mixtures of glycine and GABA at physiolog-
ical concentrations. Accordingly, presynaptic termi-
nals generally contained both transmitters, and
depleting terminals of GABA slowed glycinergic syn-
aptic currents. Thus, coreleased GABA accelerates
glycinergic transmission by acting directly on glycine
receptors, narrowing the time window for effective
inhibition. Packaging both weak and strong agonists
in vesicles may be a general means by which presyn-
aptic neurons regulate the duration of postsynaptic
responses.
INTRODUCTION
Glycine is the major inhibitory transmitter in the lower auditory
pathway; glycinergic interneurons and projection neurons mod-
ify the response to acoustic stimuli from the cochlear nucleus to
the inferior colliculus. The temporal precision of inhibition is crit-
ical for circuits involved in sound localization (Awatramani et al.,
2004; Brand et al., 2002; Tollin, 2003). Recent studies have
shown that glycinergic inhibition is mediated by extremely brief
synaptic responses, with submillisecond decay times in mature
synapses at physiological temperature (Awatramani et al.,
2004, 2005; Magnusson et al., 2005), briefer than those reported
at other glycinergic synapses (Che´ry and de Koninck, 1999;
Dugue´ et al., 2005; Singer and Berger, 1999).
GABA and glycine are coexpressed by many neurons in the
brainstem, cerebellum, and spinal cord (Dugue´ et al., 2005;
Ostapoff et al., 1997; Rubio and Juiz, 2004; Todd and Sullivan,
1990; Wenthold et al., 1987) and are packaged into synaptic524 Neuron 57, 524–535, February 28, 2008 ª2008 Elsevier Inc.vesicles by the same transporter, VIAAT, indicating that the
two transmitters are coreleased (Chaudhry et al., 1998; Sagne´
et al., 1997; Wojcik et al., 2006). Although this coexpression dis-
appears with age in some brain regions (Muller et al., 2006;
Nabekura et al., 2004), it does persist into adulthood in
a wide variety of cell types (Gleich and Vater, 1998; Korada
and Schwartz, 1999; Moore et al., 1996; Ostapoff et al., 1997;
Riquelme et al., 2001; Rubio and Juiz, 2004; Spirou and Berrebi,
1997; Wenthold et al., 1987). However, the function of corelease
remains unclear, and indeed transmission at many such synap-
ses is mediated largely by postsynaptic glycine receptors
(Che´ry and de Koninck, 1999, 2000; Lim et al., 2000; Wu and
Oertel, 1986).
It is generally believed that fast-acting neurotransmitters reach
millimolar levels in the synaptic cleft for brief periods of time and
that the decay of the postsynaptic response reflects the intrinsic
gating kinetics of the channels as transmitter unbinds and leaves
the cleft (Clements et al., 1992; Overstreet et al., 2002). We show
here that GABA at physiological concentrations speeds the de-
cay of glycine responses in membrane patches from the medial
nucleus of the trapezoid body (MNTB). The glycinergic boutons
in MNTB generally contained GABA, and depleting such termi-
nals of GABA slowed the decay time of glycine receptor-medi-
ated synaptic currents. Thus, the function of corelease may be
to enhance the temporal precision of inhibition.
RESULTS
Responses to Glycine in Membrane Patches
In rat MNTB, glycinergic terminals generate inhibitory postsyn-
aptic currents (IPSCs) that are completely blocked by 0.5 mM
strychnine (Awatramani et al., 2004). In P9–11 rats, miniature in-
hibitory postsynaptic currents (mIPSCs), each activated by the
spontaneous release of a single synaptic vesicle, sometimes
have mixed components generated by both glycine and GABAA
receptors, indicating corelease (Awatramani et al., 2005). Al-
though these mIPSCs with mixed components disappear with
age, GABA may still be coreleased with glycine. GABA is
a weak, partial agonist of glycine receptors (De Saint Jan et al.,
2001; Lewis et al., 2003). If coreleased with glycine, GABA might
alter the properties of the glycine receptor and thus shape glyci-
nergic transmission. We tested this hypothesis by excising
patches of MNTB membrane from P10–18 rats and applying gly-
cine with and without GABA, comparing the responses to synap-
tic currents. Rise times (10%–90%) to 1 mM glycine applied for
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1.04 ± 0.12 ms (n = 9). mIPSCs rose in 0.32 ± 0.01 (n = 13), sug-
gesting larger and/or briefer synaptic glycine transients than that
used on the patch. The patch response to glycine alone (1–3 mM;
1 ms pulse) decayed biexponentially with a tfast = 11 ± 1 ms,
tslow = 56 ± 5 ms, and fast%, the percent contribution to peak re-
sponse by the fast component, was 60% ± 5% (n = 40 patches;
Figures 1A and 1B). By contrast, glycine receptor-mediated
mIPSCs were much briefer, decaying biexponentially with a tfast
of 3.3 ± 0.2 ms (fast component 86% ± 3%) and a tslow of 12 ± 2
ms (n = 13 cells; Figures 1A and 1B). While time constants in
patches varied widely, perhaps an effect of receptor density on
affinity (De Saint Jan et al., 2001), only 2 of 40 patches had a tfast
similar to that of mIPSCs. This discrepancy has been previously
noted in other mammalian systems (Harty and Manis, 1998;
Singer and Berger, 1999). Control experiments explored the pos-
sibility that receptors in patches are altered as a consequence of
excision or do not represent the synaptic population. However,
the decay kinetics were not significantly faster for patches taken
from cells with synapses enzymatically stripped off, which makes
synaptic receptors more available for study, or from nucleated
patches, which better preserves cytosolic components that reg-
ulate receptors (see Figure S1B available online). Inclusion of
Figure 1. GABA Modifies the Kinetics and
Amplitude of Patch Responses to Glycine
in MNTB
(A) Normalized mIPSC (average of 300 events) and
patch response to 1 ms pulse of 1 mM glycine
(average of 20 applications to a patch excised
from the same cell). Recorded in the presence of
20 mM SR95531.
(B) Summary of decay kinetics of mIPSCs (n = 13)
and patch responses to 1–3 mM glycine for 1 ms
(n = 40). Significant difference existed for each ki-
netic parameter between the synaptic and patch
responses (p < 0.001).
(C) The left panel shows the responses of one
MNTB patch to 1 ms application of 1 mM glycine,
10 mM GABA, or a mix of both. GABAA receptors
were blocked with 20 mM SR-95531. Each trace
was the average of 10 to 20 repetitions. Peak am-
plitude of the glycine response was reduced by
about 25% with the inclusion of GABA. The accel-
eration in decay was evident when the responses
were normalized (right panel).
(D) GABA shortened the tfast of the glycine re-
sponse in all seven patches using 1 mM glycine
and 10 mM GABA.
(E) The effects of different concentrations of GABA
and glycine applied with 1 ms pulses. Data were
normalized and statistically tested against values
with glycine alone (n = 3–10 patches).
Error bars indicate ± SEM.
phalloidin in the pipette (Singer and
Berger, 1999), allowing it to diffuse into
the cell prior to patch excision, had no ef-
fect on response kinetics (Figure S1B).
Moreover, decay kinetics were un-
changed when glycine was rapidly ap-
plied to isolated whole cells (Figure S1), thus excluding the pos-
sibility that cells contain populations of fast, synaptic receptors
that may not be probed by our excised patch technique. Finally,
we examined deactivation as a function of glycine concentration
(Figure S1C), finding significantly faster deactivation only for
0.1 mM glycine, a concentration well below the EC50 of the recep-
tor using brief pulses (Jonas et al., 1998; Singer and Berger,
1999).
Zn2+ is an endogenous modulator of glycinergic signals (Smart
et al., 2004; Suwa et al., 2001). Since responses of patches and
synapses might differ because of differences in ambient Zn2+
levels (Suwa et al., 2001), we examined the effect of chelation
or application of this ion. However, chelation of Zn2+ with
5–10 mM tricine did not alter mIPSC decays (91% ± 8% of con-
trol, p = 0.31, n = 6 cells), nor did application of 1 mM free Zn2+
(10 mM tricine plus 250 mM Zn2+; 87% ± 4% of that in tricine
alone, p = 0.08, n = 3; Suwa et al., 2001). Taken together, the
data described above indicate that the differences between
patch and synaptic glycine receptors cannot be accounted for
by artifacts in the patch technique or lack of modulators.
However, patch decay kinetics were accelerated when glycine
was coapplied with millimolar levels of GABA (Figure 1C). These
concentrations of GABA were chosen because modeling studies
Neuron 57, 524–535, February 28, 2008 ª2008 Elsevier Inc. 525
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between 1 and 10 mM (Overstreet et al., 2002). As shown in Fig-
ures 1C–1E, GABA significantly accelerated the tfast and tslow of
the patch response, with only a modest reduction in peak ampli-
tude and no effect on rise time. Consistent with a competition be-
tween these two agonists, greater acceleration was seen with
greater GABA/glycine ratio (Figure 1E). Mixtures of 0.5 mM gly-
cine plus 10 mM GABA gave the briefest decays, but significant
effects were seen even with 1 mM glycine plus 3 mM GABA.
These effects of GABA were not due to contamination by GABAA
receptor responses, as they were recorded in the presence of
the GABAA receptor antagonist SR-95531 (20 mM). Moreover,
GABA alone induced no response in this condition (Figure 1C),
and all responses were completely blocked with 1 mM strychnine
(data not shown).
Postsynaptic glycine receptors in MNTB are most likely
a1-b heteromers (Friauf et al., 1997; Leao et al., 2004). We tested
the effect of GABA on patches from HEK293 cells expressing
homomeric glycine receptors consisting of a1 subunits, the
glycine-binding subunit prevalent at most mature glycinergic
synapses. Here, GABA also sped up the decay and reduced
the peak amplitude of glycine responses (Figure 2A), confirming
that the activation of GABAA receptors is not required. Possibly
because of the different subunit composition, the effect of
GABA on kinetic parameters of decay was different from that
in MNTB; GABA significantly increased fast% and reduced tslow
Figure 2. GABA Modifies the Glycine Response of Homomeric a1
Glycine Receptors
(A) The responses of a patch pulled from a HEK293 cell expressing homomeric
a1 receptors to 1 ms application of 1 mM glycine, with or without 10 mM GABA
(left panel, averages of four to six applications). The addition of GABA reduced
the peak amplitude by one-third and accelerated the decay (right panel, nor-
malized traces).
(B) Fast%, the contribution of fast component to peak response, for a1 recep-
tors was increased with the addition of GABA in all five patches tested.
(C) Unlike for MNTB glycine receptors, the fast %, but not the tfast, for a1 re-
ceptors was significantly affected by mixing 10 mM GABA with 1 mM glycine.
Moreover, GABA produced a significant reduction in tslow and peak amplitude
(n = 5).
Error bars indicate ± SEM.526 Neuron 57, 524–535, February 28, 2008 ª2008 Elsevier Inc.(Figurse 2B and 2C). Thus, by acting as a coagonist, GABA ac-
celerates the kinetics of the glycine receptor.
Although patches responded significantly faster with GABA
plus glycine, the fast decay constant still did not match the syn-
aptic waveform in MNTB. This discrepancy probably resulted
from the differences in glycine exposure time in patches versus
the synaptic cleft. When 1 mM glycine was applied for varying
durations, the decay of current following its removal was slower
for longer applications, even though the actual removal time was
identical (Figure 3A). On average, with a 2 ms application, tfast
was 10.6 ± 0.9 ms (n = 26), while for a 200 ms pulse, the tfast
was 5.7 ± 0.5 ms (n = 16, p = 0.0002; Figure 3C). When this re-
lation was constructed with a mixture of glycine and GABA, we
found that for applications of 1 ms or less, 3 mM GABA signifi-
cantly shortened the fast and slow ts compared to glycine alone
(Figures 3B–3D, p < 0.05), while 10 mM GABA had a still larger
effect. Figure 3E shows that the 200–250 ms application of
10 mM GABA paired with 1 mM glycine gave a tfast that was
faster than mIPSCs (2.5 ± 0.3 ms, n = 14, p = 0.04), while 3 mM
GABA plus 1 mM glycine gave a tfast indistinguishable from
synaptic decay times for this age range (3.4 ± 0.5 ms, n = 14,
p = 0.79). As expected, shortening the exposure time reduced
the rise times sufficiently (0.36 ± 0.02 ms, n = 26 for 0.2–0.25 ms
application, pooled from all patches with 1 mM glycine), not dif-
ferent from synaptic rise times (p = 0.14). Together, these data
suggest that very rapid glycinergic signaling may arise from co-
exposure of receptors to glycine and GABA for a submillisecond
period. We emphasize that this particular combination of gly-
cine/GABA ratio and exposure duration resulting in synaptic-
like fast time constants is probably one of a spectrum of values:
for example, lowering the GABA level combined with even
shorter pulses might give similar results. However, in the follow-
ing two sections we demonstrate the presence of presynaptic
GABA and its effectiveness in shaping the IPSC.
Immunolocalization of Transmitters in Boutons
Are these transmitters coreleased in the MNTB? Although mixed
GABAergic and glycinergic transmission was previously demon-
strated for a fraction of terminals in MNTB from P9–11 rats,
IPSCs in older animals were generally glycinergic (Awatramani
et al., 2005). It is likely, however that GABA continues to be
released. Postembedding immuno-EM was used to localize
GABA and glycine in boutons on MNTB at P10 and P16. GABA
primary antibodies were labeled with secondary antibodies con-
jugated to 10 nm gold particles, while glycine was detected using
secondary antibodies conjugated to 5 nm gold particles. Synap-
tic endings colabeled with GABA and glycine were observed on
the cell body and dendrites of MNTB neurons at both ages (Fig-
ure 4, see also Figure S2). These endings made symmetric syn-
aptic contacts, contained pleomorphic synaptic vesicles, and
were clearly distinguishable from endings containing flattened
synaptic vesicles that labeled only for glycine. The glutamatergic
calyx of Held on MNTB cell bodies lacked gold particles for either
GABA or glycine (Figure S3). As shown in Figure 5, the percent of
endings containing both transmitters was 51% at P10 and 68%
at P16, with solely glycine-containing synapses comprising 44%
and 30%, respectively, of the terminals. At the antibody concen-
tration we used, the density of glycine particles was similar in
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erating Effect of GABA Is Sensitive to the
Duration of Transmitter Exposure
(A) MNTB patch responses to applications of gly-
cine for various durations (as indicated) were nor-
malized and aligned at the decay. Each trace was
the average of 10 to 20 applications.
(B) In another MNTB patch, responses to applica-
tions of glycine paired with GABA for various dura-
tions (as indicated) were normalized and aligned at
the onset. Each trace was the average of 8 to 14
applications. The dashed lines show exponential
fits to the decays, with the respective tfast indi-
cated.
(C and D) Summary of tfast and tslow for MNTB
patch responses to applications of 1 mM glycine
alone (B) or 1 mM glycine paired with 3 mM (6)
or 10 mM GABA (,) (n = 11–28 patches for gly-
cine, and n = 4–16 for glycine plus GABA). For
each ligand or ligand mix, strong linear correlation
was found between the decay times and the loga-
rithm of the application durations (p < 0.001).
(E) Comparison of tfast values shows that, when
exposed to a mixture of glycine and GABA very
briefly, patches may respond with similar decay ki-
netics to that of synaptic currents.
Error bars indicate ± SEM.GABA/glycine-containing and glycine-only boutons at P16, and
in terminals containing both transmitters above background,
the density of particle labeling was comparable. GABA particles
were found at about half the density of glycine in the former
population and was similar at P10 and P16 (Figure 5). These
data indicate that despite the loss of cotransmission with GABAA
and glycine receptors, GABA is concentrated in the majority of
glycine-containing boutons in MNTB.
Regulation of Presynaptic GABA Content
If GABA is coreleased at a majority of synapses and results in
a speeding of glycine receptor kinetics, then reduction in pre-
synaptic GABA content should lead to slowing of glycinergic
IPSCs. GABA is generated from glutamate by glutamic acid
decarboxylase, and block of glutamate uptake into nerve termi-
nals reduces vesicular GABA content (Mathews and Diamond,
2003). We examined the effect of TBOA, a broad-spectrum
competitive antagonist of glutamate transporters (Shimamoto
et al., 1998), on decay time and amplitude of glycinergic or
GABAergic mIPSCs. Baseline values of mIPSC decay time
and amplitude were obtained from the recorded cells before
20–30 mM TBOA was bath applied for 15–25 min, followed
with wash in TBOA-free perfusate for more than 1 hr. Changes
in decay time and amplitude were expressed as percent differ-
ence from baseline values, and peak effect was measured by
pooling data between the 50th and 70th minute after TBOA ap-
plication. TBOA increased the decay time of glycinergic mIPSCs
(41% ± 3% increase, n = 9, p = 0.0001; Figures 6A, 6B, and 6D).
In the absence of TBOA, prolonged whole-cell recordings for up
to 2 hr did not change significantly the decay time of glycinergic
mIPSCs (8% ± 4% change, n = 6, p = 0.10; Figure 6D). TBOA
had only a small effect on the amplitude of glycinergic mIPSCs(15% ± 5% increase, n = 9, p = 0.04; Figure 6A). As expected
from previous studies, TBOA reduced the peak amplitude of
GABAergic mIPSCs (26% ± 4% reduction, n = 7, p = 0.0006,
Figures 6A and 6C), while in the absence of drug, peak ampli-
tude was stable throughout recordings (5% ± 4% change,
n = 3, p = 0.34; Figure 6C). TBOA did not alter the decay time
of GABAergic mIPSCs (2% ± 4% change, n = 7, p = 0.63;
Figure 6A). These effects on glycinergic decays were not due
to a direct effect of TBOA on glycine receptors, as the drug
did not change the decay time of glycine patch responses
(5% ± 9% change, n = 3, p = 0.63). Immediately upon applica-
tion to the slices (<6 min), TBOA did not significantly affect
the kinetics of glycinergic mIPSCs (8% ± 6% change, n = 10,
p = 0.22) or the peak amplitude of GABAergic mIPSCs (4% ±
4% change, n = 7, p = 0.36), consistent with the requirement
to gradually alter intraterminal transmitter GABA levels. Applica-
tion of THA, another blocker of glutamate transporters, using
the same protocol, also gradually slowed the decay times of
glycinergic mIPSCs (21% ± 4% change, n = 6, p = 0.0033;
Figure 6D), while reducing the peak amplitude of GABAergic
mIPSCs (14% ± 3% decrease, n = 3, p = 0.043; Figure 6C). An-
other source of presynaptic glutamate is glutamine, which is
taken up by the system A transporters and converted to gluta-
mate by glutaminase. Recently it has been shown that blockade
of glutamine uptake with the competitive antagonist a-(methyl-
amino) isobutyric acid (MeAIB) (Varoqui et al., 2000) also re-
duces the GABA content of synapses (Fricke et al., 2007; Liang
et al., 2006). Application of MeAIB using the same protocol also
produced a marked slowing of the glycine mIPSCs (41% ± 8%
increase, n = 6, p = 0.0037; Figure 6D) and a reduction of the
amplitude of GABAergic mIPSCs (22% ± 4% reduction, n = 4,
p = 0.012; Figure 6C).Neuron 57, 524–535, February 28, 2008 ª2008 Elsevier Inc. 527
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further in several ways. Simultaneous application of TBOA and
MeAIB for 15–25 min produced an effect similar to that of each
drug alone (p = 0.13; Figure 6D), possibly because each drug
was able to reduce vesicular GABA below a necessary threshold
concentration needed to accelerate IPSC kinetics. These data
combine recordings from P12–23 rats. When data were divided
into 2 week (P12–16) and 3 week (P22–23) age groups, there was
no significant difference in the effectiveness of the drugs (56% ±
10% increase, n = 4, versus 44% ± 2% increase, n = 4, respec-
tively; p = 0.28). Thus, it is unlikely that corelease of GABA and
glycine is developmentally downregulated in MNTB (see Discus-
sion). We next tested the specificity of these drugs by determin-
ing whether their effects on the two transport pathways could be
selectively reduced by coapplication of physiological substrates.
The effect of TBOA on mIPSC decay could be reduced by coap-
plication of 2–5 mM glutamate (p < 0.001) but not by 4–10 mM
glutamine (p = 0.89). Conversely, the effect of MeAIB was re-
duced by glutamine (p = 0.02) but not by glutamate (p = 0.62)
(Figure 6E).
An additional set of slices from P15–17 rats were incubated
for 4–8 hr in the GAD inhibitor 3-mercaptopropionic acid (MPA,
250 mM) prior to recordings (Karlsson et al., 1974). The decay
time of glycinergic mIPSCs in these slices was 4.4 ± 0.2 ms
(n = 5), 33% ± 6% slower than that in control slices (p = 0.005).
Figure 4. Presynaptic Colocalization of
GABA and Glycine
Electron micrographs show postembedding im-
munogold labeling of GABA and glycine using 10
nm and 5 nm gold particles, respectively, on bou-
tons synapsing on the cell body of MNTB neurons.
Top set of six panels (A–F) are from P10 rats, while
the lower six panels (G–L) are from P16 rats. In
each set, the upper three rows (A–C and G–I)
show examples in which both GABA and glycine
were found, while the lower three rows (D–F and
J–L) show terminals with only glycine labeling. In-
sets in each case show labeling at higher magnifi-
cation. Scale bar, 0.2 mm.
Several MPA-incubated slices were
bathed in 30 mM TBOA and 4 mM MeAIB
for another hour before recordings, and
the eventual mIPSC decay time, 4.2 ±
0.1 ms (n = 6), was indistinguishable
from that with MPA alone (p = 0.37).
These results are consistent then with
the interpretation that TBOA and MeAIB
cause a lowering of presynaptic GABA
below a critical level needed to impact
glycinergic kinetics.
Due to the limited length of recording in
single cell (<2 hr), we could not observe
the complete time course for the effect
of TBOA or MeAIB. Therefore, in a sepa-
rate series of experiments, 19 slices
(P12–17) were incubated for 20–30 min
with TBOA (20–30 mM), MeAIB (3–4 mM),
or both, then washed for up to 4 hr. When possible, consecutive
recordings were made in several cells in the slice throughout
the period. Peak effect of TBOA or MeAIB, measured as the
decay time of glycinergic mIPSCs pooled from different cells
50–150th min after incubation, revealed a roughly 50% increase
over controls (i.e., slices incubated for the same period but with-
out drugs) (Figure 6F); moreover, the glycinergic decay times fol-
lowing the incubation of TBOA (4.7 ± 0.5 ms, n = 10, p = 0.008
against control), MeAIB (5.0 ± 0.4 ms, n = 7, p = 0.002), or
both (4.5 ± 0.2 ms, n = 8, p = 0.006) were statistically indistin-
guishable from one another (p > 0.26). Partial recovery was
seen in glycinergic mIPSCs recorded after more than 2.5 hr of
wash (3.9 ± 0.2 ms, n = 9, p = 0.08 against control), suggesting
GABA may eventually be accumulated in synaptic vesicles at
significant concentrations after the interference with glutamate
supply is removed. Together these results demonstrate that re-
duction in presynaptic GABA by two independent transport
pathways led to slowing of postsynaptic glycinergic responses.
The Timing of Inhibition
The results described above suggest that cotransmission could
shorten the time window for inhibition of EPSPs. To explore
the physiological significance for this fine-tuning of synaptic
kinetics, we injected MNTB neurons at physiological tempera-
ture with excitatory and inhibitory synaptic-like inputs using528 Neuron 57, 524–535, February 28, 2008 ª2008 Elsevier Inc.
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The strength of the excitatory postsynaptic conductance
(EPSG) was fixed either at threshold (18 ± 3.5 nS, spiking prob-
ability = 0.5 ± 0.1, n = 5) or 1030% above threshold (spiking
probability = 1.0) in the absence of inhibition. Only the time delay
by which the inhibitory postsynaptic conductance (IPSG) led
EPSG was varied systematically, from 0 to 15 ms; in practice,
the action potential was completely blocked when the IPSG
led EPSG by only a few milliseconds. With the parameter set
used in Figure 7B, reducing the IPSG decay constant from
2 ms to 1 ms resulted in halving the maximal interval between
IPSG and EPSG that resulted in spike blockade.
We quantified this temporal precision needed for effective in-
hibition with an ‘‘inhibition window,’’ defined as the maximum
lead time that still allowed the IPSG to block all action potentials
induced by EPSG. With suprathreshold EPSG, the lengthening in
IPSG decay time constant resulted in a nearly proportional
expansion of the inhibition window (2.4 ± 0.2 ms for tdecay = 1
ms, 4.1 ± 0.4 ms for tdecay = 2 ms, n = 5; Figure 7C, circles). In-
Figure 5. GABA Is Present in the Majority of Glycinergic Boutons in
MNTB
(A) Histogram shows the percent of endings analyzed that were found labeled
for only GABA, only glycine, or colabeled with GABA and glycine (GABA/Gly-
cine) for P10 and P16 rats. At both ages, the GABA/Glycine endings were most
highly represented. N = 103 boutons (P10 = 59, P16 = 44) on cell bodies of
MNTB neurons.
(B and C) Density of gold particles per area of synaptic ending ± SEM in P10
and P16 rats, respectively. By P16, the density of glycine labeling was similar
in glycine-only and GABA/glycine-containing boutons.hibition window grew even more steeply for at-threshold EPSGs
(3.6 ± 0.2 ms for tdecay = 1 ms, 7.7 ± 0.5 ms for tdecay = 2 ms,
n = 5; Figure 7C, squares) and were always longer for threshold
EPSGs than for suprathreshold EPSGs (Figure 7C, squares ver-
sus circles, p < 0.01). Our data indicate that, depending on the
strength of excitatory input, a small change in the decay time
constant for inhibitory conductance may affect postsynaptic ac-
tivity for periods several times longer. This observation depends
critically on the relative strengths of EPSG and IPSG—an EPSG
several times stronger than the IPSG would render the IPSG less
effective or the inhibition window less sensitive to changes in
IPSG kinetics. However, given that the excitatory input may be
chronically depressed to near-threshold levels in vivo (Hermann
et al., 2007) and that IPSCs in MNTB do not depress as readily
(Awatramani et al., 2004), regulation of the IPSC decay time
would be likely to impact the effective coincidence time of inhib-
itory and excitatory signals.
DISCUSSION
Cotransmission Regulates Glycinergic Signals
Colocalization and release of GABA and glycine is widespread in
inhibitory neurons of the brainstem and spinal cord. We show for
the first time that GABA, coreleased with glycine from the same
vesicles, acts as a coagonist to modify the response of glycine
receptors to glycine. In the MNTB, and elsewhere in the auditory
pathway where rapid phasic signaling is required for processing
of acoustic information, this novel form of cotransmission ap-
pears to be well suited to refining the kinetics of inhibition. The
MNTB transmits inhibitory signals to nuclei of the superior olive
with delays, in cats, of less than 200 ms (Joris and Yin, 1998), em-
phasizing the importance of structural and physiological adapta-
tions in the MNTB to reducing synaptic and conduction delays
(Taschenberger et al., 2002). This rapid inhibition is utilized in en-
coding interaural intensity, and possibly also timing differences,
in the lateral and medial superior olives (LSO and MSO), respec-
tively (Brand et al., 2002; Tollin, 2003). MNTB neurons best acti-
vated by a given frequency of sound can be inhibited by sounds
of higher or lower frequencies (Kopp-Scheinpflug et al., 2003);
such glycinergic inhibition is triggered and terminated rapidly
with the onset and offset of the sideband stimuli. The kinetics
of glycinergic signals would impact how quickly such acoustic
inhibition could act during complex, behaviorally relevant
sounds. Corelease of GABA and glycine, combined with short
transmitter lifetimes, allow inhibition to sculpt precisely the
response pattern of the MNTB.
Colocalization of GABA and glycine are characteristic of neo-
natal brain, and shifts from cotransmission to glycine-only trans-
mission have been documented in several brain regions (Awatra-
mani et al., 2005; Kotak et al., 1998; Muller et al., 2006; Nabekura
et al., 2004). In some cases, loss of presynaptic GABA may un-
derlie this shift (Muller et al., 2006; Nabekura et al., 2004). Our re-
sults indicate that, in other cases, GABA release may be retained
by older animals, even when IPSCs are no longer mediated by
GABAA receptors. GABA and glycine were found in the majority
of MNTB terminals in P16 rats, when GABA was reported miss-
ing in LSO and motoneurons (Muller et al., 2006; Nabekura et al.,
2004). In P16 rats, the GABA labeling was absent in aboutNeuron 57, 524–535, February 28, 2008 ª2008 Elsevier Inc. 529
Neuron
Cotransmission Determines IPSC Decay TimeFigure 6. Reduction in Intraterminal GABA Concentration Slows the
Decay of Glycinergic Synaptic Responses
(A) The running average (every 3 min) of the decay times and peak amplitude of
glycinergic (C) or GABAergic mIPSC (:), normalized to baseline values. Gly-
cinergic mIPSCs (n = 9 cells, rats aged P10–19) and GABAergic mIPSCs (n = 7
cells, rats aged P10–15) were both pharmacologically isolated. Metabotropic
glutamate receptors and GABAB receptors were blocked with a cocktail of an-
tagonists including 20 mM LY-341495, 30 mM E4CPG, 30 mM CPPG, and 2 mM
CGP-54828.
(B1) Normalized glycinergic mIPSCs, averaged over the baseline period or over
the 50–70th min following TBOA application in one cell (P18). (B2) Distributions
of the decay time constant for glycinergic mIPSCs over these same periods
from same cell. Both distributions for the baseline (lightly shaded) and after-
TBOA (hollow envelope) events were best fitted with a Gaussian distribution
(dashed line).
(C) The effect of TBOA (20–30 mM), THA (300 mM), and MeAIB (4 mM) on intra-
terminal GABA concentration, measured by baseline-normalized peak ampli-
tude of GABAergic mIPSC about 1 hr following a 15–25 min bath application of
each blocker. In control experiments where blockers were not added, pro-
longed recordings for up to 1.5 hr revealed no significant change. Numbers
in parentheses indicate number of cells; statistical significance was tested
against the baseline.
(D) Baseline-normalized decay times for glycinergic mIPSCs in a similar series
of experiments. The increases mirrored the reductions in amplitude of GA-
BAergic mIPSCs. Control recordings in the absence of blockers showed that
decay kinetics were stable for up to 2 hr.
(E) Effect of TBOA on the decay time of glycinergic mIPSCs was significantly
reduced with coapplication of glutamate (2–5 mM), but not glutamine
(4–10 mM). Conversely, the effect of MeAIB was reduced only with the coap-
plication of glutamine. Note statistical significance was tested against the ef-
fects of TBOA or MeAIB alone.530 Neuron 57, 524–535, February 28, 2008 ª2008 Elsevier Inc.one-third of the glycine-labeled boutons, where the intraterminal
GABA level might have been too low for the antibody to pick up.
Nevertheless, these boutons may still corelease some GABA,
because the vesicular transporter has a higher affinity for
GABA than for glycine, and the vesicles accumulate GABA twice
as fast (Christensen and Fonnum, 1991; McIntire et al., 1997).
Our data do not support that a significant portion of glycinergic
synapses in MNTB are distinct in not coreleasing GABA at all, be-
cause the mIPSC decay times were best described with a Gauss-
ian distribution (Figure 6B2). Moreover, no difference was seen in
the ability of glutamate uptake blockers to prolong IPSCs be-
tween ages P10 to P23. On the other hand, the significant reduc-
tion in coefficient of variation for these decay times from baseline
to 1 hr following TBOA application (0.35 ± 0.04 versus 0.27 ±
0.03, n = 9, p = 0.013) suggested an intersynaptic variability in
GABA content that could be reduced with interference in
GABA synthesis. Given the persistence of coexpression of these
two transmitters in a subset of adult glycinergic neurons in other
species as well, including baboon, bat, cat, guinea pig, and rat
(Alibardi, 2003; Kemmer and Vater, 1997; Kolston et al., 1992;
Moore et al., 1996; Osen et al., 1990; Ostapoff et al., 1997; Rubio
and Juiz, 2004; Saint Marie et al., 1991, 1997; Wenthold and
Hunter, 1990), it seems likely that cotransmission is a general
means for fine-tuning glycinergic transmission in the mature
auditory system.
Such a role for modulated inhibition stands in sharp contrast to
purely GABAergic signaling within the auditory brainstem. IPSCs
mediated by GABAA receptors not only provide stable inhibition
during acoustic stimuli, but also sharply reduce excitability for
tens of milliseconds after a stimulus (Klug et al., 1999; Kulesza
et al., 2007; Pecka et al., 2007). This is a result both of the slower
GABAA receptor deactivation after each stimulus, but also en-
hanced asynchronous quantal release (Lu and Trussell, 2000;
Pecka et al., 2007). It is interesting in this regard that even within
the MNTB, transmission mediated by GABAA and glycine recep-
tors differ significantly in both decay times and the time course of
quantal release (Awatramani et al., 2005). These results highlight
that GABA may be used for very distinct purposes characterized
by different time courses, depending on whether it targets
GABAB, GABAA, or glycine receptors.
Other roles for cotransmission by GABA and glycine have
been proposed. Where both ionotropic receptors are present,
GABA and glycine produce IPSCs with a distinct multiphasic
time course (Awatramani et al., 2005; Jonas et al., 1998; Russier
et al., 2002). Terminals of cerebellar Golgi cells corelease both
transmitters, but their postsynaptic effects vary with the target:
granule cells only sense GABA, and unipolar brush cells only
sense glycine (Dugue´ et al., 2005). In spinal dorsal horn neurons,
coreleased GABA acts on extrasynaptic GABAA receptors only
during intense activation (Che´ry and de Koninck, 2000).
(F) In separate experiments, 19 slices were incubated for 20–30 min with TBOA
(20–30 mM), MeAIB (3–4 mM), or both, then washed for up to 4 hr in perfusate
containing the same mGluR and GABAB blockers as above. ‘‘Peak effect’’ was
obtained from events pooled during the 50–150 min after incubation. Partial re-
covery in glycinergic decay time was seen in recordings made after 2.5 hr of
wash (data pooled from all three conditions).
Error bars indicate ± SEM.
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and glycine release in spinal cord and cochlear nucleus (Che´ry
and de Koninck, 1999; Lim et al., 2000). Our results indicate
that, apart from any secondary action of GABA outside the syn-
aptic cleft, the two transmitters may work together at a single re-
ceptor to enhance the temporal resolution of inhibition.
Recent studies suggest that presynaptic glutamate pools
maintained by plasma membrane transporters support GABAer-
gic transmission. Our study indicates that these pools may also
play a role in GABA/glycine cotransmission. Several differences
were observed with some previous work. We found that effects
of transport blockers arose only after a long delay and recovered
incompletely. Given that our study focused on measurements of
mIPSCs rather than evoked events, this delay may reflect the
slow turnover of vesicle populations in unstimulated synapses
or the gradual depletion of endogenous GABA levels. Recovery
of GABA-filled vesicles may reflect differences in refilling rates
for GABA versus glycine (Katsurabayashi et al., 2004). Liang
Figure 7. Inhibition Window of Inhibitory Conductance Was Highly
Sensitive to Changes in Decay Kinetics
(A) Schematic of two-electrode conductance-clamp strategy.
(B) Top lines show timing and durations of IPSGs. Lower lines are voltage
traces shown at two gain settings, all from a single cell. The EPSG had
a peak value of 21 nS and produced a spiking probability of 100% in the ab-
sence of IPSG. The IPSG had a constant peak magnitude of 25 nS, and was
delivered in this example either 2 or 4 ms before EPSG. Action potential is
marked with an asterisk. Lower plots show firing probability versus relative tim-
ing of IPSG-EPSG onsets for this cell.
(C) Inhibition window, defined as the maximum lead time the IPSG had before
the EPSG and still block all action potentials. This window expands proportion-
ally to the decay time constant of IPSGs. Linear fit to the data had a slope of
1.9 for suprathreshold EPSG (circles), 3.0 for threshold EPSG (squares), and
a correlation coefficient >0.98 for both (n = 5 neurons).
Error bars indicate ± SEM.et al. (2006) observed an effect of MeAIB only on IPSCs following
high-frequency synaptic activity and could not occlude this ac-
tion with exogenous glutamine. Other groups have observed
acute and reversible effects of MeAIB on mIPSCs or low-fre-
quency evoked IPSCs (Chaudhry et al., 2002; Fricke et al.,
2007). By contrast, we observed an effect of MeAIB on mIPSCs
after a long delay and found competition of the effect by gluta-
mine, as expected for transported substrates (Varoqui et al.,
2000). It is possible that glutamine and MeAIB could reversibly
alter release by depolarizing synapses (Chaudhry et al., 2002;
Kam and Nicoll, 2007). This confound could not account
for our results, since we only measured mIPSCs after MeAIB
washout.
Exposure Dependence of Current Decays
Glycine receptors deactivated more slowly following longer ap-
plications of glycine. This effect was previously noted by Mo-
hammadi et al. (2003) for longer-duration pulses on glycine re-
ceptors and may be relatively common to synaptic receptors.
For example, Zhang et al. (2006) observed this effect in heterol-
ogously expressed AMPA receptors, ascribing it to progressive
occupancy of more openable states as more agonist molecules
bind. Jones and Westbrook (1995) found a similar effect for
GABA receptors and argued that longer GABA exposure leads
to slower deactivation as desensitized receptors transiently re-
open before unbinding. Regardless of the kinetic mechanism,
this effect may have significant impact on synaptic transmission,
since the time course of transmitter might vary with subtle varia-
tion in synaptic morphology or density and distribution of trans-
porters (Cathala et al., 2005; Renden et al., 2005).
Mechanism of Glycine-GABA Interactions
Our results show that GABA acted directly on the glycine-binding
subunit of the glycine receptor. Previous studies indicated that
GABA is a weak partial agonist of the receptor, producing
smaller currents with a much higher EC50 of tens of millimolar
(De Saint Jan et al., 2001; Jonas et al., 1998; Lewis et al.,
2003). Moreover, gabazine, an effective antagonist of GABAA re-
ceptors, is a low-affinity antagonist of glycine receptors (Beato
et al., 2007), further emphasizing that glycine binding sites
have limited selectivity for ligands characteristic of both glycine
and GABAA receptors. Glycine receptors require occupation of
two to three sites for full activation, although channel opening
by fewer ligands might occur (Burzomato et al., 2004), producing
open states of shorter duration. Consistent with competition at
these binding sites, the effect of GABA on peak amplitude and
decay kinetics increased with the GABA/glycine ratio. Two sce-
narios might account for the more rapid kinetics we see when
glycine receptors are exposed to both GABA and glycine. First,
the occupation of a fraction of the binding sites by GABA might
simply displace glycine molecules and induce channel openings
characteristic of a partially glycine-bound receptor. This possi-
bility cannot fully account for our observations, since applica-
tions of glycine concentrations between 0.3 and 10 mM did not
exhibit differences in current deactivation time (Figure S1C),
and concentrations lower than these would give open probabil-
ities too low to be consistent with estimated values at synapses
(Jonas et al., 1998; Rigo et al., 2003; Singer and Berger, 1999;Neuron 57, 524–535, February 28, 2008 ª2008 Elsevier Inc. 531
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that channel gating properties (e.g., stability of the active, open
state) depend upon the identity of the bound ligand (Colquhoun
and Sakmann, 1985; Del Castillo and Katz, 1957). Indeed, gly-
cine receptors activated by very high concentrations of GABA
have deactivation times ten times faster than receptors activated
by glycine (Fucile et al., 1999). We propose the stability of the
channel open state of receptors (and thus the deactivation
time) with both GABA and glycine bound is intermediate be-
tween the glycine-bound or GABA-bound receptors. Because
this effect of GABA is characteristic of the major glycine-binding
subunit in the brain, we suggest that its coagonist role in trans-
mission may be common to all glycinergic synapses where co-
localization is found. Our results provide a novel mechanism by
which postsynaptic responses may be modulated. Other modu-
lators of synaptic kinetics may either operate at the level of the
entire cell, changing its membrane time constant, or alter the
structure of the postsynaptic receptor, subunit composition, or
phosphorylation state. Our results suggest that by combining
weak or partial agonists with full agonists in single vesicles, syn-
apses may take advantage of the wide range of affinities of differ-
ent endogenous compounds for receptor sites in order to fine-
tune the duration of the postsynaptic response. In principle,
such a mechanism has the advantage of tuning the magnitude
and duration of a synapse-specific postsynaptic effect by grad-
ing the relative concentrations of transmitters.
EXPERIMENTAL PROCEDURES
Preparations and Solutions
The handling and care of animals was approved by the OHSU and University of
Connecticut Institutional Animal Care & Use Committees. Brainstem slices
(200 mm) were prepared from P10–23 Wistar rats in low-Ca2+, low-Na+ saline
(Awatramani et al., 2004, 2005) and incubated in 30C ACSF for 1 hr before re-
cording. The ACSF for incubation and recording contained (in mM) 125 NaCl,
25 NaHCO3, 5 KCl, 2 CaCl2, 1 MgCl2, 1 NaH2PO4, 0.4 L-ascorbic acid, 3 myo-
inositol, 2 Na-pyruvate, and 25 glucose (pH 7.4, saturated with 95% O2/5%
CO2). NaCl and HEPES replaced NaHCO3 for the ACSF used on outside-out
patches. The protocol for isolating MNTB neurons were adapted from that
used previously (Raman et al., 1994). The recording pipettes were filled with
(in mM) 130 CsCl, 10 TEA.Cl, 2 MgCl2, 10 HEPES, 5 BAPTA.Cs4, 4 QX-
314.Cl, and 2–4 Mg.ATP (pH 7.2 with CsOH). Glutamate or GABA receptor an-
tagonists (50 mM APV, 20 mM DNQX, 20 mM SR-95531) and 1 mM tetrodotoxin
were included in the ACSF when recording glycinergic miniature IPSCs.
Strychnine (0.5–1 mM) was substituted for SR-95531 when recording GABAer-
gic miniature IPSCs. All synaptic activity was blocked in the presence of glu-
tamate-, GABA-, and glycine-receptor antagonists. Reagents were from
Sigma-Aldrich, Tocris, and Alamone.
Homomeric Receptor Expression
Human embryonic kidney 293 cells (HEK293) (American Type Culture Collec-
tion-CRL-1573) were maintained at 37C in a 95% air/5% CO2 incubator in
DMEM supplemented with 0.11 g/l sodium pyruvate, 10% v/v heat-inactivated
fetal bovine serum, 100 U/ml penicillin G, 100 mg/ml streptomycin sulfate, and
2 mM L-glutamine and passaged every 2–3 days, up to 20 times. Cells were
plated on coverslips, to reach a moderate density, and then transfected by Lip-
ofectamin reagent with cDNAs for the human a1 receptor subunit, a gift of
Dr. J. Mihic, UT Austin. cDNA for enhanced green fluorescent protein plasmid
(EGFP-c1) was cotransfected with 3 mg of receptor cDNA to allow detec-
tion of transfected cells. Patch-clamp recordings were made 14–48 hr after
transfection.532 Neuron 57, 524–535, February 28, 2008 ª2008 Elsevier Inc.Recordings
Whole-cell and outside-out patch recordings were made at room temperature.
Recording pipettes pulled from borosilicate glass typically had a resistance of
3–5 MU, and in whole-cell recordings the series resistance was compensated
by 80% using an Axopatch 200B amplifier (Molecular Devices). Holding poten-
tial was –60 mV.
Drug Application
The fabrication of theta-pipettes and set-up of piezo-driven fast-flow system
was as previously described (Raman et al., 1994). The 20%–80% solution
exchange time, measured by the instant change in open-tip junction potential
between the normal and a 10%-diluted ACSF, was typically 30–80 ms. Two
three-way manifolds were installed close to the back of the theta-pipette,
and consequently both the control and test solutions could be completely
changed within 20 s. Control experiments were conducted to estimate the so-
lution exchange time over intact patches and whether effective agonist con-
centration at receptors is reduced for very brief applications (see Figure S4
and associated text). This was accomplished by applying 1 mM kainic acid
to patches and measuring the change in current upon rapid exchange of
Na+ concentration from 40 to 140 mM. The results showed that the rise time
of such responses were slightly slower than with junction potential measure-
ments on the same electrodes (130 ms versus 76 ms). For our shortest applica-
tions (0.2–0.25 ms), the reduction in agonist concentration was 13%–17% and
was essentially full-amplitude for longer applications (Figure S4).
Conductance Clamp
Two-electrode whole-cell recordings were made from P15–18 neurons at
35C–37C; the membrane potential was monitored through one electrode,
whereas the simulated synaptic currents from a conductance clamp circuit
(SM-1, Cambridge Conductance, Cambridge, UK) were injected through the
other. This configuration eliminated the error in membrane potential resulting
from the large injection currents passing across the electrode series resis-
tance. Electrode internal solution contained (in mM) 147 K-gluconate, 5 KCl,
1 MgCl2,10 HEPES, 4 BAPTA, 4 Mg-ATP, pH 7.2, with correction for a 12
mV junction potential. EPSGs were generated by the sum of two exponentials
with trise = 0.1 ms, tdecay = 0.4 ms, and set to reverse at 0 mV; IPSGs were gen-
erated by the sum of two exponentials with trise = 0.2 ms, tdecay = 13 ms, and
set to reverse at –75 mV (Awatramani et al., 2004, 2005). The peak IPSG was
set to 2030 nS, based on reported amplitude of single-axon evoked IPSCs
(Awatramani et al., 2005). After first determining threshold excitatory conduc-
tance needed to trigger 50% firing probability, we set the peak EPSG to thresh-
old or 10%–30% above threshold. The IPSG was delivered at 0–15 ms (at
intervals %1 ms, in random order) before the EPSG. The EPSG-IPSG pairing
was repeated 100 times at 2–10 Hz.
Electron Microscopy
A total of two P10 and two P16 Sprague-Dawley rats were used in these exper-
iments. A mixture of ketamine (60 mg/kg body weight) and xylazine (6.5 mg/kg
body weight) was injected intramuscularly to induce deep anesthesia before
transcardial perfusion with 4% paraformaldehyde and 0.5% glutaraldehyde
in 0.12 M phosphate buffer, pH 7.2. Brains were removed, fixed for an hour
at 4C, rinsed in buffer, and stored overnight at 4C. Brainstems were sliced
on a vibratome and the slices processed for freeze-substitution technique fol-
lowed by postembedding immunogold labeling (see below). The MNTB was
trimmed from 300 mm thick brainstem sections and processed for freeze-sub-
stitution and low-temperature embedding as previously described (Rubio,
2006; Rubio and Wenthold, 1997). Double postembedding immunogold label-
ing for GABA and glycine (1:400 each; Chemicon, Temecula) was performed
as previously described (Rubio, 2006). Primary antibodies were labeled with
5 nm (Glycine) or 10 nm (GABA) colloidal gold-coupled secondary antibodies
(Amersham, Piscataway). Controls were carried out by omitting the primary
antibody in the immunogold labeling. Immunostaining was analyzed with
a TECNAI 12 Biotwin TEM. The images were captured with an AMT CCD cam-
era at 49,0003 magnification. Image processing was performed with Adobe
Photoshop by using only the brightness and contrast commands to enhance
gold particles. The quantitative analysis of GABA and glycine on synaptic end-
ings on cell bodies of MNTB neurons was analyzed in a total of 103 endings
Neuron
Cotransmission Determines IPSC Decay Time(P10 n = 59 and P16 n = 44). The density of gold particles for GABA and/or gly-
cine was computed using JScion NIH image for each synaptic ending profile
by dividing the number of gold particles in a synaptic ending profile by the cy-
toplasmic area of that profile. The average density was computed across all
profiles. The synaptic ending were classified as GABAergic if they were only
immunogold labeled for GABA, glycinergic for only glycine, and GABA/Gly
when they were double labeled for GABA and glycine. The three categories
of synaptic endings contained flattened and/or pleomorphic synaptic vesicles
and made Gray Type II symmetric synapses on the cell bodies of MNTB neu-
rons; some of these endings were also observed on dendrites. Gold particles
on mitochondria or on putative excitatory synapses containing rounded syn-
aptic vesicles were low and were considered background, and their density
subtracted from that measured at inhibitory terminals. A bouton was consid-
ered labeled if it contained more than four particles; the background levels
for either glycine or GABA was therefore a maximum of three particles, and
the majority of unlabeled structures had between zero or two particles.
Data Analyses and Statistics
The current responses were acquired in pClamp 9 (Molecular Devices) and
analyzed with Axograph 4.9 (Molecular Devices) and Igor 5.0 (Wavemetrics).
Unless specified otherwise, summary data were presented as mean ± SEM,
and statistical significance was established using t tests as appropriate.
SUPPLEMENTAL DATA
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/57/4/524/DC1/.
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